Abstract
The use of phytic acid (and/or sodium phytates) in resealed erythrocytes and consequently the potential in vivo administration of the substance was the reason for an analytical examination about the commercially available products. The purity and the structure of a 12 Na phytate (biochemical reagent) were investigated. Finally a reference substance was prepared.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
L.R. Isbranst and R.P. Oertel, Conformational states of myo-inositol hexakis (phosphate) in aqueous solutions. A 13C NMR, 31P NMR and Raman spectroscopic investigation, J. Am. Chem. Soc., 102:3144 (1980).
B.S. Szwergold, R.A. Graham and T.R. Brown, Observation of inositol pentakis-and hexakis-phosphates in mammalian tissues by 31P NMR, Biochem. Biophys. Res. Comm., 149:874 (1987).
The Merck Index, 11 Ed., 7359: 1172.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Crimella, T., Villa, S., Rossi, F., Fiorelli, G., Zanella, A. (1992). Determination of Purity of Commercially Available Inositol Hexaphosphate (Phytates) and Preparation of a Reference Material. In: Magnani, M., DeLoach, J.R. (eds) The Use of Resealed Erythrocytes as Carriers and Bioreactors. Advances in Experimental Medicine and Biology, vol 326. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3030-5_6
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3030-5_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6321-7
Online ISBN: 978-1-4615-3030-5
eBook Packages: Springer Book Archive